Annual Working Capital
$2.75 B
-$290.50 M-9.57%
31 December 2023
Summary:
United Therapeutics annual working capital is currently $2.75 billion, with the most recent change of -$290.50 million (-9.57%) on 31 December 2023. During the last 3 years, it has risen by +$728.40 million (+36.09%). UTHR annual working capital is now -9.57% below its all-time high of $3.04 billion, reached on 31 December 2022.UTHR Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
$3.13 B
+$339.80 M+12.19%
30 September 2024
Summary:
United Therapeutics quarterly working capital is currently $3.13 billion, with the most recent change of +$339.80 million (+12.19%) on 30 September 2024. Over the past year, it has increased by +$380.40 million (+13.85%). UTHR quarterly working capital is now at all-time high.UTHR Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
UTHR Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +13.8% |
| 3 y3 years | +36.1% | +54.9% |
| 5 y5 years | +96.0% | +123.1% |
UTHR Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -9.6% | +36.1% | at high | +54.9% |
| 5 y | 5 years | -9.6% | +96.0% | at high | +123.1% |
| alltime | all time | -9.6% | >+9999.0% | at high | >+9999.0% |
United Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $3.13 B(+12.2%) |
| June 2024 | - | $2.79 B(+16.7%) |
| Mar 2024 | - | $2.39 B(-13.1%) |
| Dec 2023 | $2.75 B(-9.6%) | $2.75 B(+1.2%) |
| Sept 2023 | - | $2.71 B(-4.5%) |
| June 2023 | - | $2.84 B(-0.9%) |
| Mar 2023 | - | $2.87 B(-5.6%) |
| Dec 2022 | $3.04 B(+50.5%) | $3.04 B(+10.8%) |
| Sept 2022 | - | $2.74 B(+16.5%) |
| June 2022 | - | $2.35 B(+2.6%) |
| Mar 2022 | - | $2.29 B(+13.7%) |
| Dec 2021 | $2.02 B(+9.5%) | $2.02 B(-2.3%) |
| Sept 2021 | - | $2.07 B(+3.0%) |
| June 2021 | - | $2.01 B(+17.2%) |
| Mar 2021 | - | $1.71 B(-7.2%) |
| Dec 2020 | $1.84 B(+31.6%) | $1.84 B(+14.6%) |
| Sept 2020 | - | $1.61 B(-1.8%) |
| June 2020 | - | $1.64 B(+0.0%) |
| Mar 2020 | - | $1.64 B(+16.9%) |
| Dec 2019 | $1.40 B(-6.0%) | $1.40 B(-4.2%) |
| Sept 2019 | - | $1.46 B(-12.7%) |
| June 2019 | - | $1.68 B(+0.2%) |
| Mar 2019 | - | $1.67 B(+12.1%) |
| Dec 2018 | $1.49 B(+48.7%) | $1.49 B(+20.6%) |
| Sept 2018 | - | $1.24 B(-3.0%) |
| June 2018 | - | $1.27 B(-3.1%) |
| Mar 2018 | - | $1.32 B(+31.1%) |
| Dec 2017 | $1.00 B(-8.2%) | $1.00 B(+18.1%) |
| Sept 2017 | - | $849.80 M(+17.2%) |
| June 2017 | - | $724.90 M(-32.7%) |
| Mar 2017 | - | $1.08 B(-1.5%) |
| Dec 2016 | $1.09 B(+30.9%) | $1.09 B(+2.0%) |
| Sept 2016 | - | $1.07 B(+4.7%) |
| June 2016 | - | $1.02 B(+8.5%) |
| Mar 2016 | - | $942.50 M(+12.9%) |
| Dec 2015 | $834.60 M(+84.1%) | $834.60 M(+24.3%) |
| Sept 2015 | - | $671.18 M(+134.2%) |
| June 2015 | - | $286.63 M(-17.5%) |
| Mar 2015 | - | $347.34 M(-23.4%) |
| Dec 2014 | $453.28 M(+99.9%) | $453.28 M(+42.6%) |
| Sept 2014 | - | $317.84 M(+42.8%) |
| June 2014 | - | $222.53 M(-32.9%) |
| Mar 2014 | - | $331.73 M(+46.3%) |
| Dec 2013 | $226.71 M(-53.9%) | $226.71 M(-51.1%) |
| Sept 2013 | - | $463.83 M(-5.6%) |
| June 2013 | - | $491.36 M(-26.4%) |
| Mar 2013 | - | $667.96 M(+35.8%) |
| Dec 2012 | $491.71 M(+40.5%) | $491.71 M(+0.2%) |
| Sept 2012 | - | $490.57 M(+28.1%) |
| June 2012 | - | $382.94 M(-3.9%) |
| Mar 2012 | - | $398.38 M(+13.9%) |
| Dec 2011 | $349.88 M | $349.88 M(-16.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2011 | - | $421.18 M(-0.7%) |
| June 2011 | - | $423.97 M(+14.9%) |
| Mar 2011 | - | $368.89 M(+9.9%) |
| Dec 2010 | $335.80 M(-6012.0%) | $335.80 M(+67.0%) |
| Sept 2010 | - | $201.02 M(+33.5%) |
| June 2010 | - | $150.57 M(+116.0%) |
| Mar 2010 | - | $69.71 M(-1327.2%) |
| Dec 2009 | -$5.68 M(-102.4%) | -$5.68 M(-126.9%) |
| Sept 2009 | - | $21.12 M(-90.0%) |
| June 2009 | - | $211.66 M(+2.0%) |
| Mar 2009 | - | $207.60 M(-13.4%) |
| Dec 2008 | $239.75 M(+200.8%) | $239.75 M(+8474.9%) |
| Sept 2008 | - | $2.80 M(-126.4%) |
| June 2008 | - | -$10.58 M(-104.0%) |
| Mar 2008 | - | $267.41 M(+235.5%) |
| Dec 2007 | $79.70 M(-69.1%) | $79.70 M(-68.6%) |
| Sept 2007 | - | $254.08 M(+13.7%) |
| June 2007 | - | $223.53 M(+11.9%) |
| Mar 2007 | - | $199.69 M(-22.6%) |
| Dec 2006 | $258.12 M(+69.6%) | $258.12 M(+61.1%) |
| Sept 2006 | - | $160.19 M(-12.7%) |
| June 2006 | - | $183.41 M(+8.6%) |
| Mar 2006 | - | $168.96 M(+11.0%) |
| Dec 2005 | $152.23 M(+57.5%) | $152.23 M(+17.3%) |
| Sept 2005 | - | $129.77 M(+17.0%) |
| June 2005 | - | $110.88 M(+3.3%) |
| Mar 2005 | - | $107.38 M(+11.1%) |
| Dec 2004 | $96.63 M(+22.2%) | $96.63 M(+3.0%) |
| Sept 2004 | - | $93.77 M(+11.5%) |
| June 2004 | - | $84.09 M(+7.2%) |
| Mar 2004 | - | $78.47 M(-0.8%) |
| Dec 2003 | $79.10 M(-40.3%) | $79.10 M(-10.0%) |
| Sept 2003 | - | $87.88 M(-11.0%) |
| June 2003 | - | $98.74 M(-0.4%) |
| Mar 2003 | - | $99.15 M(-25.2%) |
| Dec 2002 | $132.55 M(+127.7%) | $132.55 M(-8.8%) |
| Sept 2002 | - | $145.36 M(-8.4%) |
| June 2002 | - | $158.64 M(+128.5%) |
| Mar 2002 | - | $69.43 M(+19.3%) |
| Dec 2001 | $58.20 M(-72.4%) | $58.20 M(-40.3%) |
| Sept 2001 | - | $97.44 M(-39.2%) |
| June 2001 | - | $160.20 M(-13.7%) |
| Mar 2001 | - | $185.63 M(-11.9%) |
| Dec 2000 | $210.63 M(+337.9%) | $210.63 M(-9.6%) |
| Sept 2000 | - | $232.94 M(+122.2%) |
| June 2000 | - | $104.82 M(-7.6%) |
| Mar 2000 | - | $113.47 M(+135.9%) |
| Dec 1999 | $48.10 M(+220.7%) | $48.10 M(-16.3%) |
| Sept 1999 | - | $57.50 M(+1.1%) |
| June 1999 | - | $56.90 M(+321.5%) |
| Mar 1999 | - | $13.50 M |
| Dec 1998 | $15.00 M | - |
FAQ
- What is United Therapeutics annual working capital?
- What is the all time high annual working capital for United Therapeutics?
- What is United Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for United Therapeutics?
- What is United Therapeutics quarterly working capital year-on-year change?
What is United Therapeutics annual working capital?
The current annual working capital of UTHR is $2.75 B
What is the all time high annual working capital for United Therapeutics?
United Therapeutics all-time high annual working capital is $3.04 B
What is United Therapeutics quarterly working capital?
The current quarterly working capital of UTHR is $3.13 B
What is the all time high quarterly working capital for United Therapeutics?
United Therapeutics all-time high quarterly working capital is $3.13 B
What is United Therapeutics quarterly working capital year-on-year change?
Over the past year, UTHR quarterly working capital has changed by +$380.40 M (+13.85%)